March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Microarray Retinal Gene Profile Expression Analysis And Serum VEGF Analysis In Dogs With Spontaneously Occurring Autoimmune Retinopathy (AIR)
Author Affiliations & Notes
  • Tatjana Lazic
    Center for Prevention and Treatment of Vision Loss, Dept of Veterans Affairs-Iowa City, Iowa City, Iowa
  • Markus H. Kuehn
    Center for Prevention and Treatment of Vision Loss, Dept of Veterans Affairs-Iowa City, Iowa City, Iowa
    Ophthalmology and Visual Sciences, University of Iowa, Iowa City, Iowa
  • Dina Ahram
    Center for Prevention and Treatment of Vision Loss, Dept of Veterans Affairs-Iowa City, Iowa City, Iowa
    Ophthalmology and Visual Sciences, University of Iowa, Iowa City, Iowa
  • Randy H. Kardon
    Center for Prevention and Treatment of Vision Loss, Dept of Veterans Affairs-Iowa City, Iowa City, Iowa
    Ophthalmology and Visual Sciences, University of Iowa, Iowa City, Iowa
  • Sinisa Grozdanic
    Center for Prevention and Treatment of Vision Loss, Dept of Veterans Affairs-Iowa City, Iowa City, Iowa
  • Footnotes
    Commercial Relationships  Tatjana Lazic, None; Markus H. Kuehn, None; Dina Ahram, None; Randy H. Kardon, None; Sinisa Grozdanic, None
  • Footnotes
    Support  Department of Veterans Affairs – Center for Prevention and Treatment of Vision Loss, Sophie’s SARDs Research Fund.
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 2238. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tatjana Lazic, Markus H. Kuehn, Dina Ahram, Randy H. Kardon, Sinisa Grozdanic; Microarray Retinal Gene Profile Expression Analysis And Serum VEGF Analysis In Dogs With Spontaneously Occurring Autoimmune Retinopathy (AIR). Invest. Ophthalmol. Vis. Sci. 2012;53(14):2238.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate retinal gene expression profile of non-paraneoplastic autoimmune retinopathy (npAIR) and cancer associated retinopathy (CAR) in dogs with spontaneously occurring disease, and determine whether VEGF serum levels are increased in the serum of AIR patients

Methods: : Microarray analysis was performed on 6 eyes of npAIR dogs, and 4 eyes of CAR dogs. Immunohistochemistry was used to validate microarray targets. Serum VEGF levels were measured using the ELISA in 56 AIR dogs, 25 dogs with primary glaucoma and 13 healthy control dogs.

Results: : Microarray analysis of CAR and npAIR canine retinas revealed increased expression of genes associated with antigen presentation (2.2-6 fold increase compared to controls), immunoglobulin synthesis (2-26 fold increase), complement (2.1-5.2 fold increase), apoptosis (3.3-5.4 fold increase), and pro-inflammatory mediators (2-18 fold increase). Decreased expression was associated predominantly with different families of photoreceptor and smooth muscle genes. VEGF ELISA analysis from canine patient serum samples revealed significantly higher levels in AIR (10.2+/-2.7 pg/ml, mean+/-SEM, p<0.05, ANOVA) and glaucoma patients (4.7+/-1.3 pg/ml, p<0.05, ANOVA), compared to healthy controls (1.1+/-1.1 pg/ml). There was no statistically significant difference between VEGF serum concentration in glaucoma and AIR patients (p>0.1).

Conclusions: : Molecular analysis of retinal tissue revealed similar profile of gene expression changes in npAIR and CAR patients. VEGF serum levels were increased in AIR patients compared to control samples, however there was no statistically significant difference between AIR and glaucoma patients. At this time, it is not clear whether this change is a significant feature of the AIR pathology or just the reactive change in response to the retinal damage.

Keywords: autoimmune disease • retina • gene/expression 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×